Literature DB >> 8280680

Prognostic factors following enucleation of 111 uveal melanomas.

K Coleman1, J P Baak, P Van Diest, J Mullaney, M Farrell, M Fenton.   

Abstract

Follow up information was retrieved on 111 patients who underwent enucleation for uveal melanoma between 1964 and 1987, allowing a minimum postoperative period of 5 years. Univariate survival analysis was carried out using Kaplan-Meier curves and the differences between the curves were analysed with the Mantel-Cox test. Multivariate analysis used the Cox proportional hazards model. Univariate analysis isolated each of the following as significant prognosticators: largest tumour diameter (LTD) (p < 0.002), presence of epithelioid cells (p < 0.03), and glaucoma (p < 0.001). A combination of cell type, glaucoma, and LTD (p < 0.0001) had strong and independent prognostic significance in multivariate analysis. The results of this series are compared with previous studies and the value of cell type information and new quantitative parameters is discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8280680      PMCID: PMC504624          DOI: 10.1136/bjo.77.11.688

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  The uses and limitations of intraocular biopsy.

Authors:  W S Foulds
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

2.  MALIGNANT MELANOMA OF CHOROID. REPORT OF A CASE WITH CLINICAL HISTORY OF 36 YEARS AND FOLLOW UP OF 32 YEARS.

Authors:  F H NEWTON
Journal:  Arch Ophthalmol       Date:  1965-02

3.  A review of mortality from choroidal melanoma. I. Quality of published reports, 1966 through 1988.

Authors:  J A Markowitz; B S Hawkins; M Diener-West; A P Schachat
Journal:  Arch Ophthalmol       Date:  1992-02

4.  A comparison of prognostic covariates for uveal melanoma.

Authors:  J W Gamel; J B McCurdy; I W McLean
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-05       Impact factor: 4.799

5.  Mlalignant melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952.

Authors:  O A Jensen
Journal:  Acta Ophthalmol (Copenh)       Date:  1970

6.  A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.

Authors:  M Diener-West; B S Hawkins; J A Markowitz; A P Schachat
Journal:  Arch Ophthalmol       Date:  1992-02

7.  Choroidal melanoma. Enucleation or observation? A new approach.

Authors:  W A Manschot; H A van Peperzeel
Journal:  Arch Ophthalmol       Date:  1980-01

8.  DNA content abnormalities and prognosis in uveal melanoma.

Authors:  W J Meecham; D H Char
Journal:  Arch Ophthalmol       Date:  1986-11

9.  Prognostic factors in malignant melanoma of the choroid: a retrospective survey of cases occurring in Northern Ireland between 1965 and 1980.

Authors:  M N Kidd; R W Lyness; C C Patterson; P B Johnston; D B Archer
Journal:  Trans Ophthalmol Soc U K       Date:  1986

10.  Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943--1952.

Authors:  O A Jensen
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-04
View more
  14 in total

1.  Precision of ultrasonic estimates of choroidal melanoma regression.

Authors:  R Rask; P K Jensen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

2.  Delayed systemic recurrence of uveal melanoma.

Authors:  Nathalie A Kolandjian; Caimiao Wei; Sapna P Patel; Jessica L Richard; Tina Dett; Nicholas E Papadopoulos; Agop Y Bedikian
Journal:  Am J Clin Oncol       Date:  2013-10       Impact factor: 2.339

3.  Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation.

Authors:  K A Patel; N D Edmondson; F Talbot; M A Parsons; I G Rennie; K Sisley
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

4.  Endodrainage, Tumor Photocoagulation, and Silicone Oil Tamponade for Primary Exudative Retinal Detachment due to Choroidal Melanoma Persisting after Proton Beam Therapy.

Authors:  Ira Seibel; Dino Cordini; Gregor Willerding; Aline Isabel Riechardt; Antonia Maria Joussen
Journal:  Ocul Oncol Pathol       Date:  2014-07-22

5.  Alpha/beta- and gamma/delta TCR(+) lymphocyte infiltration in necrotising choroidal melanomas.

Authors:  A A Bialasiewicz; J X Ma; G Richard
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

6.  Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma.

Authors:  A J Foss; I Whelehan; J L Hungerford; D F Anderson; R D Errington; A Kacperek; M Restori; J Kongerud; M Sheen
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

7.  NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS.

Authors:  Ashwin Nair; Paul Thevenot; Wenjing Hu; Liping Tang
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

8.  Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma.

Authors:  I Kaiserman; I Anteby; I Chowers; E Z Blumenthal; I Kliers; J Pe'er
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

9.  Syntactic structure analysis in uveal melanomas.

Authors:  K Coleman; P J van Diest; J P Baak; J Mullaney
Journal:  Br J Ophthalmol       Date:  1994-11       Impact factor: 4.638

10.  Nanoparticles for Uveal Melanoma Treatment.

Authors:  Sheng Zhang; Jun Zhou; Zhibing Hu; Ashwin Nair; Liping Tang
Journal:  Proc IEEE Conf Nanotechnol       Date:  2008-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.